Jonathan Trent on Trabectedin for Soft Tissue Sarcoma Published 2015-12-22 Download video MP4 360p Recommendations 08:20 Trabectedin in Soft Tissue Sarcoma 03:00 Sarcoma Warrior Stories: Soft Tissue Sarcoma Survivor 08:14 Understanding the Persistent Symptoms in Lyme Disease | Johns Hopkins Medicine 01:02 What is the Importance of the Roller for Fibrosis? 03:53 Soft tissue Sarcoma cancer | A diagnostic and treatment overview | #cancer 08:08 What kind of cancer does Kate have? Doctor says likely Stage 1 12:21 Yondelis® (trabectedin) Mechanism of Action for Liposarcoma and Leiomyosarcoma 01:46 Sarcoma survivor cancer-free for 50 years 04:49 Current Treatment Landscape of Soft Tissue Sarcoma 04:14 Sarcoma Cancer Care | The Role of the Medical Oncologist - Karim Boudadi, M.D. 17:31 Mayo Clinic Q&A podcast: Be aware of the rare cancer called sarcoma 01:18 Dr. Martee Hensley on Trabectedin as a Treatment for Uterine Leiomyosarcoma 03:22 Developing targeted therapies for soft tissue sarcomas 09:59 Lyme Story #2 - Jonah Cummings, Living with Lyme 04:57 Sarcoma Diagnosis and Treatment at the CU Cancer Center 05:46 Second-Line Therapy Options: Role of Trabectedin 07:40 Promising new treatments for sarcomas: immunotherapy and fusion targeted compounds 02:22 Trabectedin or Dacarbazine for Treatment of Patients With Advanced Leiomyosarcoma or Liposarcoma 02:08 Dr. Porter on the 3-Year Follow-Up Data From the CheckMate-9LA Trial in NSCLC 08:14 Efficacy and Toxicities with Trabectedin in Sarcomas Similar videos 01:16 Dr. Jonathan Trent on FDA Approval of Trabectedin for Soft Tissue Sarcomas 01:30 Dr. Trent on Sequencing Trabectedin for Patients With Soft Tissue Sarcoma 01:18 Dr. Jonathan Trent on Pembrolizumab in Advanced Sarcomas 00:54 Dr. Trent on the Role of ctDNA in Soft Tissue Sarcoma 00:54 Jonathan C. Trent, MD, PhD: Clinical Data Supporting the Use of Trabectedin 02:13 ECCO14: Trabectedin for metastatic or advanced soft tissue sarcoma 01:00 Jonathan C. Trent, MD, PhD: Pattern of This Patient’s Metastatic Disease 01:16 Jonathan C. Trent, MD, PhD: Trabectedin in Advanced, Invasive Myxoid Liposarcoma 04:22 Multidisciplinary Assessment is Critical for Soft Tissue Sarcoma 05:40 The Future of Treatment for Soft Tissue Diseases 01:02 Jonathan C. Trent, MD, PhD: Leiomyosarcoma Differing From Those Arising at Other Sites 03:40 Management of Oligometastases in Soft-Tissue Sarcoma 01:04 How has the trabectedin extended access program benefited sarcoma patients? 04:26 The Role of Trabectedin in Sarcoma Subtypes 02:13 Dr. Jon Trent Discusses his top picks on the use of immunotherapy in Sarcomas during #ASCO20 01:28 Jonathan C. Trent, MD, PhD: Principle Treatment Goals for This Patient More results